|
|
|
|
Hepatocyte growth factor: From diagnosis to clinical applications.
Funakoshi H. and Nakamura T.Clin. Chim. Acta. (2003) 327: 1-23. |
|
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases.
Matsumoto K. and Nakamura T.Kidney Int. (2001) 59: 2023-2038. |
|
Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics.
Matsumoto K., Mizuno S. and Nakamura T. Curr. Opin. Nephrol. Hypertens. (2000) 9: 395-402. |
NK4 (Selected review papers)
|
Mechanisms and significance of bifunctional NK4 in cancer treatment.
Matsumoto K. and Nakamura T. Biochem. Biophys. Res. Commun. (2005) 333: 316-327. |
|
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
Jiang W.G. et al. Crit. Rev. Oncol. Hematol. (2005) 53: 35-69. |
|
NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics.
Matsumoto K. and Nakamura T. Cancer Sci. (2003) 94: 321-327. |
